H.Pylori Infection Clinical Trials

14 recruitingLast updated: June 18, 2026

There are 14 actively recruiting h.pylori infection clinical trials across 39 countries. Studies span Not Applicable, Phase 4, Phase 2. Top locations include Seoul, South Korea, Riga, Latvia, Sohag, Egypt. Updated daily from ClinicalTrials.gov.


H.Pylori Infection Trials at a Glance

14 actively recruiting trials for h.pylori infection are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Seoul, Riga, and Sohag. Lead sponsors running h.pylori infection studies include Soonchunhyang University Hospital, Sohag University, and National Taiwan University Hospital.

Browse h.pylori infection trials by phase

About H.Pylori Infection Clinical Trials

Looking for clinical trials for H.Pylori Infection? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new H.Pylori Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about H.Pylori Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Tegoprazan- Versus PPI-based H. Pylori Eradication

H.Pylori Infection
Soonchunhyang University Hospital200 enrolled1 locationNCT06682533
Recruiting
Not Applicable

H. Pylori Eradication With Argon Plasma During Endoscopy

Helicobacter Pylori InfectionHelicobacter PyloriH.Pylori Infection+2 more
Christopher C. Thompson, MD, MSc20 enrolled1 locationNCT06529159
Recruiting
Phase 4

CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Eradication

H.Pylori InfectionH. Pylori Gastrointestinal DiseaseH.Pylori Eradication Rate
Dow University of Health Sciences942 enrolled1 locationNCT07344506
Recruiting
Phase 2

Efficacy of Carminal in Helicobacter Pylori Gastritis

H.Pylori InfectionGastritis Associated With Helicobacter PyloriH Pylori Gastritis+2 more
Catalysis SL80 enrolled2 locationsNCT07179237
Recruiting
Not Applicable

Screening Strategy for Gastric Cancer Prevention

H.Pylori Infection
National Taiwan University Hospital4,403 enrolled1 locationNCT05387005
Recruiting
Not Applicable

Recurrence of H Pylori : Incidence and Influential Factors.

H.Pylori Infection
Sohag University100 enrolled1 locationNCT07045857
Recruiting
Not Applicable

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

H.Pylori Infection
Sohag University150 enrolled1 locationNCT07045688
Recruiting

Tegoprazan and Amoxicillin Dual Therapy

H.Pylori Infection
Soonchunhyang University Hospital50 enrolled1 locationNCT06950489
Recruiting

RUT vs. Molecular Testing for H. Pylori

H.Pylori Infection
Soonchunhyang University Hospital100 enrolled1 locationNCT06684860
Recruiting

European Registry on the Management of Helicobacter Pylori Infection

H.Pylori Infection
Javier P. Gisbert10,000 enrolled30 locationsNCT02328131
Recruiting

Argentinean Registry on the Management of Helicobacter Pylori Infection

H.Pylori InfectionH. Pylori Gastrointestinal Disease
University of Buenos Aires5,000 enrolled1 locationNCT06579365
Recruiting

H. Pylori Screen-and-treat Study in a Population of Young Adults

Gastric CancerH.Pylori InfectionH Pylori Eradication+1 more
University of Latvia6,800 enrolled7 locationsNCT06275204
Recruiting
Phase 4

Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection

H.Pylori Infection
National Taiwan University Hospital1,200 enrolled1 locationNCT04713670
Recruiting

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Gastric CancerAtrophic GastritisGastric Dysplasia+1 more
University of Latvia5,000 enrolled5 locationsNCT04022109